Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
707 participants
OBSERVATIONAL
2020-04-14
2021-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Governments around the world have introduced differing forms of lock downs since the start of the pandemic demanding citizens to confine to their homes and go out only in necessity to minimize exposure to the virus. The response was observed in the emergency departments and the number of patients who presented for non-Covid issues drastically reduced.
Hospitals activated their mass casualty management plans and have reorganized and overstretched their capacity to be able to absorb both the influx of patients with the virus and those with other conditions.
Part of that reorganization was reducing the surgical activity. The main focus was shifted to patients who are considered urgent and elective surgery were postponed. Hence only surgical emergencies were maintained. Many did not present to the emergency department for fear to contract the virus and from a sense of national and global solidarity against that pandemic.
Whereas these measures are essential to prevent the spread of the virus, it may be hypothesized that for non-Covid issues, including surgical emergencies, patients may present late to the emergency department due to fear of contracting the infection in hospital. This would delay their management and lead to a worsened symptomology on presentation requiring a more complex surgical intervention with an increased complication profile.
The investigators present initial data from four major hospitals in Belgium, characterizing surgical emergencies that were managed since the start of the pandemic and discuss the repercussion the pandemic has on management of urgent surgical patients and most likely evolution of surgery after the pandemic.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg)
NCT04323644
Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic
NCT04389463
The Impact of the COVID-19 Pandemic on the Patient in Need of an Intervention
NCT05736822
The Effect of COVID-19 Infection on Post-operative Complications
NCT05677815
Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital
NCT04430062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Surgical intervention
Patients who had a surgical procedure since the start of the lockdown in Belgium due to the COVID19 pandemic (16 of March 2020 to the 12 of April 2020.
Data extraction from medical files
Data extraction from medical files
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data extraction from medical files
Data extraction from medical files
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brugmann University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pierre Wauthy
Medical Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yasser Farid
Role: STUDY_DIRECTOR
CHU Brugmann
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St Pierre
Brussels, , Belgium
CHU Brugmann
Brussels, , Belgium
Erasme
Brussels, , Belgium
UZ Brussel
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUB-Farid
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.